 Ferrosoferric Oxide
"Ferrosoferric Oxide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Iron (II,III) oxide (Fe3O4). It is a black ore of IRON that forms opaque crystals and exerts strong magnetism.
| Descriptor ID |
D052203
|
| MeSH Number(s) |
D01.490.100.375 D01.490.200.350 D01.578.285
|
| Concept/Terms |
Ferrosoferric Oxide- Ferrosoferric Oxide
- Oxide, Ferrosoferric
- Ferriferrous Oxide
- Oxide, Ferriferrous
|
Below are MeSH descriptors whose meaning is more general than "Ferrosoferric Oxide".
Below are MeSH descriptors whose meaning is more specific than "Ferrosoferric Oxide".
This graph shows the total number of publications written about "Ferrosoferric Oxide" by people in this website by year, and whether "Ferrosoferric Oxide" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 1 | 2 | | 2010 | 1 | 0 | 1 | | 2012 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 | | 2016 | 2 | 1 | 3 | | 2017 | 2 | 1 | 3 | | 2018 | 0 | 1 | 1 | | 2019 | 1 | 1 | 2 | | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ferrosoferric Oxide" by people in Profiles.
-
Oden CP, Werth CJ, Notini L, Katz LE. Fate of pyrene on mineral surfaces during thermal remediation as a function of temperature. Environ Sci Process Impacts. 2022 Aug 17; 24(8):1181-1194.
-
Bush AM, Sandino CM, Ramachandran S, Ong F, Dwork N, Zucker EJ, Syed AB, Pauly JM, Alley MT, Vasanawala SS. Rosette Trajectories Enable Ungated, Motion-Robust, Simultaneous Cardiac and Liver T2 * Iron Assessment. J Magn Reson Imaging. 2020 12; 52(6):1688-1698.
-
Wang G, Serkova NJ, Groman EV, Scheinman RI, Simberg D. Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II. Mol Pharm. 2019 10 07; 16(10):4274-4281.
-
Gifford G, Vu VP, Banda NK, Holers VM, Wang G, Groman EV, Backos D, Scheinman R, Moghimi SM, Simberg D. Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55. J Control Release. 2019 05 28; 302:181-189.
-
Aghighi M, Theruvath AJ, Pareek A, Pisani LL, Alford R, Muehe AM, Sethi TK, Holdsworth SJ, Hazard FK, Gratzinger D, Luna-Fineman S, Advani R, Spunt SL, Daldrup-Link HE. Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical Translation. Clin Cancer Res. 2018 09 01; 24(17):4110-4118.
-
Benasutti H, Wang G, Vu VP, Scheinman R, Groman E, Saba L, Simberg D. Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population. Bioconjug Chem. 2017 11 15; 28(11):2747-2755.
-
Ripley B, Wilson GJ, Lalwani N, Briller N, Neligan PC, Maki JH. Initial Clinical Experience with Dual-Agent Relaxation Contrast for Isolated Lymphatic Channel Mapping. Radiology. 2018 Feb; 286(2):705-714.
-
Zucker EJ, Cheng JY, Haldipur A, Carl M, Vasanawala SS. Free-breathing pediatric chest MRI: Performance of self-navigated golden-angle ordered conical ultrashort echo time acquisition. J Magn Reson Imaging. 2018 01; 47(1):200-209.
-
Hempel JC, Poppelaars F, Gaya da Costa M, Franssen CF, de Vlaam TP, Daha MR, Berger SP, Seelen MA, Gaillard CA. Distinct in vitro Complement Activation by Various Intravenous Iron Preparations. Am J Nephrol. 2017; 45(1):49-59.
-
Muehe AM, Feng D, von Eyben R, Luna-Fineman S, Link MP, Muthig T, Huddleston AE, Neuwelt EA, Daldrup-Link HE. Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults. Invest Radiol. 2016 Apr; 51(4):221-227.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|